Investors Recent News Sep 24, 2021 Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares Sep 22, 2021 Leap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants Sep 21, 2021 Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants View All Upcoming Events There are no upcoming events at this time. View All Past Events Sep 17, 2021 at 8:00 AM EDT ESMO 2021 DisTinGuish Study Conference Call Supporting Materials ESMO 2021 DisTinGuish Study Presentation 2.4 MB Sep 15, 2021 at 3:10 PM EDT Baird 2021 Global Healthcare Conference Sep 13, 2021 at 7:00 AM EDT H.C. Wainwright 23rd Annual Global Investment Conference View All
Sep 24, 2021 Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
Sep 22, 2021 Leap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants
Sep 21, 2021 Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Sep 17, 2021 at 8:00 AM EDT ESMO 2021 DisTinGuish Study Conference Call Supporting Materials ESMO 2021 DisTinGuish Study Presentation 2.4 MB
